Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $56.31 Average Price Target from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has earned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $56.31.

A number of equities research analysts have recently issued reports on ACHC shares. Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. KeyCorp reduced their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, March 3rd. TD Cowen reduced their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $43.00 to $35.00 in a report on Friday, February 28th. Finally, Bank of America reduced their price target on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th.

Acadia Healthcare Price Performance

ACHC stock opened at $28.54 on Wednesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. Acadia Healthcare has a 1 year low of $27.61 and a 1 year high of $82.40. The firm has a market cap of $2.65 billion, a P/E ratio of 9.36, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The stock has a 50-day simple moving average of $40.15 and a 200-day simple moving average of $48.73.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. State Street Corp lifted its holdings in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares during the last quarter. SG Americas Securities LLC lifted its holdings in Acadia Healthcare by 713.3% during the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock worth $4,396,000 after buying an additional 97,235 shares during the last quarter. Beach Point Capital Management LP bought a new position in Acadia Healthcare during the 4th quarter worth approximately $14,097,000. Finally, LMR Partners LLP bought a new stake in shares of Acadia Healthcare in the 3rd quarter worth approximately $1,616,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.